Skip to content

The characteristics and correlation study of intestinal microbiota and plasma metabolomics in patients with sepsis-induced cardiomyopathy

The characteristics and correlation study of intestinal microbiota and plasma metabolomics in patients with sepsis-induced cardiomyopathy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081507
Enrollment
Unknown
Registered
2024-03-04
Start date
2024-03-05
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

sepsis-induced cardiomyopathy group:None
sepsis-induced non-cardiomyopathy group:None

Sponsors

Subei People's Hospital of Jiangsu province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Age =18 years old; ? It meets the diagnostic criteria of Sepsis-3 and sepsis-induced cardiomyopathy.

Exclusion criteria

Exclusion criteria: ? Pregnancy; ? History of chronic cardiac insufficiency; ? Severe arrhythmia may affect the results of ultrasonic measurement; ?Moderate to severe mitral and/or aortic valve disease; ?History of chronic intestinal disease, such as Crohn's disease, ulcerative colitis, etc.; ? Patients undergoing colostomy or ileostomy; ? Sepsis was diagnosed more than 24 hours before enrollment; ? The estimated survival time before enrollment is less than 24 hours; ? No echocardiogram was performed within 72 hours or the echocardiogram images were not clear.

Design outcomes

Primary

MeasureTime frame
Gut microbiota;Metabolomics of plasma;Fecal metabolomics;

Secondary

MeasureTime frame
troponin;myoglobin;CK-MB;white blood cell;neutrophil;procalcitonin;albumin;creatinine;urea nitrogen;lactic acid;SOFA score;APACHEII score;ICU length of stay;ultrasonic cardiogram;

Countries

China

Contacts

Public ContactYu Jiangquan

Subei People's Hospital of Jiangsu province

yujiangquan2021@163.com+86 180 5106 0659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026